About Us
Services
Customized Market Research
Syndicated Market Research Reports
Transaction & Legal Intelligence Advisory
Industries
+
Aerospace & Defense
Airport Operations
Aviation
Communication Navigation & Surveillance
Defense
Naval Marine & Ports Technologies
Space Technologies
Unmanned Systems
+
Agriculture
Agriculture & Farming
Agriculture Equipment & Machinery
Agriculture Technology
Animal Nutrition
Crop Protection
Fertilizers
Seed & Seed Technology
+
Automotive & Transportation
Automotive Processes
Automotive Services
Automotive Technology
Autonomous Vehicles
Chasis & Body
Electric Vehicle
Powertrain
Railways
Transportation & Logistics
+
BFSI
Financial Services
Insurance Services
+
Chemicals & Materials
Adhesives & Sealants
Advanced Materials
Biobased Chemicals
Commodity Chemicals
Glass Ceramics & Fibers
Industrial Gases
Metals & Minerals
Paints & Coatings
Plastics, Polymers, and Elastomers
Specialty Chemicals
Water & Wastewater Treatment
+
Consumer Goods
Apparel, Footwear & Accessories
Appliances
Baby Care
Beauty & Personal Care
Gaming
Home Products & Utilities
Retailing
Sports & Fitness
Travel & Tourism
+
Energy & Power
Battery
Biofuels
Environment
Marine
Mining Services
Oil & Gas
Power Equipment
Power Generation
Renewable Energy
Wires & Cables
+
Food & Beverage
Beverages Products
Food Ingredients & Food Additives
Food Processing & Processed Food
Food Products
Food Supplements
+
Healthcare
Animal Health
Biotechnology
Healthcare IT
Healthcare Services
Medical Devices
Pharmaceuticals
+
Information & Technology
Artificial Intelligence
Data Center
FinTech
IT Hardware
IT Software
Media & Entertainment
Software & Services
Technology
Telecom
+
Machinery & Equipment
Automation
Construction & Engineering
Electrical Equipment & Services
Industrial Equipment
Industrial Goods
Machinery
Manufacturing Services
Refrigeration Equipment
+
Packaging
Advanced Packaging
Packaging Machinery
Packaging Products
Packaging Supplies
Packaging Technology
Printing & Labelling
+
Professional & Commercial Services
Commercial Services
Consumer & B2C Services
Professional Services
+
Real Estate & Construction
Construction
Construction Equipment
Construction Materials
Real Estate
+
Semiconductor & Electronics
Electronic Components
Integrated Circuit (IC)
Semiconductor Components
Semiconductor Foundries
Data Insights
Press Releases
Case Studies
Statistics
Blogs
Articles
Contact Us
0
Home
Information & Technology
Artificial Intelligence
Artificial Intelligence (AI) in Life Sciences Market
Artificial Intelligence (AI) in Life Sciences Market Size, Share & Trends Analysis Report By Technology (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Others), By Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring, Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug), By Drug Type (Small Molecule, Large Molecule), By Offering (Software, Services), By Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Others), By End user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Research Centres And Academic Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034
Last Updated:
May 25, 2026
|
Author:
Pavan Warade
|
Format:
|
Report Code:
SR2356DR |
Pages:
157
Overview
TOC
Segmentation
Methodology
Download Free Sample
Segmentation
Overview
TOC
Segmentation
Methodology
Download Free Sample
Market Segmentation
Artificial Intelligence (AI) in Life Sciences Market, By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Artificial Intelligence (AI) in Life Sciences Market, By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Artificial Intelligence (AI) in Life Sciences Market, By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Artificial Intelligence (AI) in Life Sciences Market, By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Artificial Intelligence (AI) in Life Sciences Market, By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Artificial Intelligence (AI) in Life Sciences Market, By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Regional Artificial Intelligence (AI) in Life Sciences Market
North America
North America Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
North America Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
North America Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
North America Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
North America Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
North America Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
U.S. Artificial Intelligence (AI) in Life Sciences Market
U.S. Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
U.S. Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
U.S. Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
U.S. Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
U.S. Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
U.S. Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Canada Artificial Intelligence (AI) in Life Sciences Market
Canada Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Canada Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Canada Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Canada Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Canada Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Canada Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Europe
Europe Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Europe Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Europe Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Europe Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Europe Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Europe Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
U.K. Artificial Intelligence (AI) in Life Sciences Market
U.K. Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
U.K. Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
U.K. Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
U.K. Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
U.K. Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
U.K. Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Germany Artificial Intelligence (AI) in Life Sciences Market
Germany Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Germany Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Germany Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Germany Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Germany Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Germany Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
France Artificial Intelligence (AI) in Life Sciences Market
France Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
France Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
France Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
France Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
France Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
France Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Spain Artificial Intelligence (AI) in Life Sciences Market
Spain Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Spain Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Spain Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Spain Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Spain Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Spain Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Italy Artificial Intelligence (AI) in Life Sciences Market
Italy Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Italy Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Italy Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Italy Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Italy Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Italy Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Russia Artificial Intelligence (AI) in Life Sciences Market
Russia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Russia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Russia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Russia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Russia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Russia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Nordic Artificial Intelligence (AI) in Life Sciences Market
Nordic Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Nordic Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Nordic Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Nordic Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Nordic Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Nordic Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Benelux Artificial Intelligence (AI) in Life Sciences Market
Benelux Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Benelux Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Benelux Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Benelux Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Benelux Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Benelux Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
APAC
APAC Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
APAC Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
APAC Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
APAC Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
APAC Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
APAC Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
China Artificial Intelligence (AI) in Life Sciences Market
China Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
China Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
China Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
China Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
China Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
China Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Korea Artificial Intelligence (AI) in Life Sciences Market
Korea Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Korea Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Korea Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Korea Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Korea Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Korea Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Japan Artificial Intelligence (AI) in Life Sciences Market
Japan Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Japan Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Japan Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Japan Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Japan Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Japan Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
India Artificial Intelligence (AI) in Life Sciences Market
India Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
India Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
India Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
India Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
India Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
India Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Australia Artificial Intelligence (AI) in Life Sciences Market
Australia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Australia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Australia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Australia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Australia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Australia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Taiwan Artificial Intelligence (AI) in Life Sciences Market
Taiwan Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Taiwan Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Taiwan Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Taiwan Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Taiwan Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Taiwan Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
South East Asia Artificial Intelligence (AI) in Life Sciences Market
South East Asia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
South East Asia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
South East Asia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
South East Asia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
South East Asia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
South East Asia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Middle East and Africa
Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
UAE Artificial Intelligence (AI) in Life Sciences Market
UAE Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
UAE Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
UAE Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
UAE Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
UAE Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
UAE Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Turkey Artificial Intelligence (AI) in Life Sciences Market
Turkey Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Turkey Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Turkey Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Turkey Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Turkey Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Turkey Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
South Africa Artificial Intelligence (AI) in Life Sciences Market
South Africa Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
South Africa Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
South Africa Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
South Africa Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
South Africa Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
South Africa Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Egypt Artificial Intelligence (AI) in Life Sciences Market
Egypt Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Egypt Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Egypt Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Egypt Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Egypt Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Egypt Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Nigeria Artificial Intelligence (AI) in Life Sciences Market
Nigeria Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Nigeria Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Nigeria Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Nigeria Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Nigeria Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Nigeria Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
LATAM
LATAM Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
LATAM Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
LATAM Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
LATAM Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
LATAM Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
LATAM Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Brazil Artificial Intelligence (AI) in Life Sciences Market
Brazil Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Brazil Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Brazil Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Brazil Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Brazil Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Brazil Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Mexico Artificial Intelligence (AI) in Life Sciences Market
Mexico Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Mexico Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Mexico Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Mexico Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Mexico Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Mexico Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Argentina Artificial Intelligence (AI) in Life Sciences Market
Argentina Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Argentina Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Argentina Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Argentina Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Argentina Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Argentina Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Chile Artificial Intelligence (AI) in Life Sciences Market
Chile Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Chile Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Chile Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Chile Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Chile Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Chile Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Colombia Artificial Intelligence (AI) in Life Sciences Market
Colombia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Colombia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Colombia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Colombia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Colombia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Colombia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
Machine Learning (ML)
Deep Learning (DL)
Natural Language Processing (NLP)
Others
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision and Personalized Medicine
Patient Monitoring
Novel Drug Candidates
Drug Optimization and Repurposing Preclinical Testing and Approval
Drug Monitoring
Finding New Diseases Associated Targets and Pathways
Understanding Disease Mechanisms
Aggregating and Synthesizing Information
Formation & Qualification of Hypotheses
De Novo Drug Design
Finding Drug Targets of an Old Drug
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
Small Molecule
Large Molecule
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
Software
Services
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Others
Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Research Centres And Academic Institutes
Others
200+
Trusted Partners
Download Free Sample
Get This Report
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
We are featured on:
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
Quick Links
About Us
Media Citations
Services
Statistics
Articles
Help
Terms & Conditions
Privacy Policy
Journalist Enquiry
Contact Us
Careers
Verified. Protected. Secure.
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright
. All rights Reserved.